BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30006791)

  • 1. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.
    Pyra M; Brown ER; Haberer JE; Heffron R; Celum C; Bukusi EA; Asiimwe S; Katabira E; Mugo NR; Baeten JM;
    AIDS Behav; 2018 Nov; 22(11):3718-3725. PubMed ID: 30006791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships.
    Ngure K; Velloza J; Patel RC; Mugo NR; Bukusi EA; Haberer JE; Odoyo J; Celum C; Baeten JM; Heffron R
    Int J STD AIDS; 2020 Nov; 31(13):1263-1271. PubMed ID: 32998640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.
    Pyra M; Haberer JE; Heffron R; Kidoguchi L; Brown ER; Bukusi EA; Asiimwe S; Celum C; Katabira E; Mugo NR; Baeten JM;
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):41-45. PubMed ID: 29016523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
    Matthews LT; Heffron R; Mugo NR; Cohen CR; Hendrix CW; Celum C; Bangsberg DR; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):91-7. PubMed ID: 25118795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.
    Musinguzi N; Kidoguchi L; Mugo NR; Ngure K; Katabira E; Celum CL; Baeten JM; Heffron R; Haberer JE;
    BMC Public Health; 2020 Oct; 20(1):1621. PubMed ID: 33115478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE; Baeten JM; Campbell J; Wangisi J; Katabira E; Ronald A; Tumwesigye E; Psaros C; Safren SA; Ware NC; Thomas KK; Donnell D; Krows M; Kidoguchi L; Celum C; Bangsberg DR
    PLoS Med; 2013; 10(9):e1001511. PubMed ID: 24058300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda.
    Ortblad KF; Stalter RM; Bukusi EA; Ngure K; Mujugura A; Celum C; Baeten JM; Heffron R
    AIDS Behav; 2020 May; 24(5):1365-1375. PubMed ID: 31696370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial.
    Haberer JE; Bukusi EA; Mugo NR; Pyra M; Kiptinness C; Oware K; Garrison LE; Thomas KK; Musinguzi N; Morrison S; Anderson PL; Ngure K; Baeten JM;
    Lancet HIV; 2021 Mar; 8(3):e130-e137. PubMed ID: 33662265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.
    Velloza J; Baeten JM; Haberer J; Ngure K; Irungu E; Mugo NR; Celum C; Heffron R;
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):330-338. PubMed ID: 30063651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.
    Haberer JE; Ngure K; Muwonge T; Mugo N; Katabira E; Heffron R; Musinguzi N; Bangsberg DR; Celum C; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):488-492. PubMed ID: 28961676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use.
    Musinguzi N; Pyra M; Bukusi EA; Mugo NR; Baeten JM; Haberer JE;
    AIDS Behav; 2023 Jan; 27(1):171-181. PubMed ID: 35841463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.
    Heffron R; Thomson K; Celum C; Haberer J; Ngure K; Mugo N; Bukusi E; Katabira E; Odoyo J; Bulya N; Asiimwe S; Tindimwebwa E; Baeten JM;
    AIDS Behav; 2018 Jun; 22(6):1758-1765. PubMed ID: 28894986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.
    Muwonge TR; Ngure K; Katabira E; Mugo N; Kimemia G; Burns BFO; Musinguzi N; Bambia F; Baeten JM; Heffron R; Haberer JE;
    AIDS Behav; 2019 May; 23(5):1267-1276. PubMed ID: 30406335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
    Roberts ST; Haberer J; Celum C; Mugo N; Ware NC; Cohen CR; Tappero JW; Kiarie J; Ronald A; Mujugira A; Tumwesigye E; Were E; Irungu E; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):313-322. PubMed ID: 27243900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.